GS vs RTX: Which Is the Better Buy?

Side-by-side comparison of The Goldman Sachs Group, Inc. and RTX Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-06-20.
The Goldman Sachs Group, Inc. Β· Financial Services
$1,096.56
-45.0% upside to fair value
Grade C High Quality
VS
RTX Corporation Β· Industrials
$185.60
-25.2% upside to fair value
Grade D
QuantHub Verdict
RTX has more upside to fair value (-25.2%). GS trades at a lower forward P/E (19.8x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric GS RTX
Current Price $1,096.56 $185.60
Fair Value Estimate $603.11 $138.81
Upside to Fair Value -45.0% -25.2%
Market Cap $323.5B $249.9B
Forward P/E 19.8x 34.3x
EV / EBITDA 42.8x 18.3x
Price / Sales 2.9x 2.8x
Price / FCF -7.7x 29.9x
Revenue Growth YoY -45.4% +8.7%
Gross Margin 55.5% 20.2%
Operating Margin 20.5% 10.9%
Return on Equity 14.6% 11.2%
Dividend Yield 0% 0%
FCF Yield β€” 3.34%
Analyst Consensus Hold Buy
Investment Thesis
GS β€” The Goldman Sachs Group, Inc.
The Goldman Sachs Group, Inc. operates as a leading global financial services firm with a strong presence in investment banking, global markets, and asset and wealth management. The company benefits from a durable competitive moat based on scale, brand, client relationships, and technology infrastructure. However, recent financial data shows a significant 45.4% year-over-year revenue decline in t…
RTX β€” RTX Corporation
RTX Corporation is a leading aerospace and defense company with a strong competitive moat driven by scale and an installed base in commercial aerospace via Pratt & Whitney and Collins Aerospace, and defense through Raytheon. The company benefits from a large multi-year backlog of approximately $270 billion supporting steady cash flow and mid-single-digit organic growth. Despite solid revenue grow…
Accumulation Zones
Metric GS RTX
Zone Low $452.33 $104.11
Zone High $512.64 $117.99
In Buy Zone? No No
← GS Research    RTX Research β†’    All Research